UNC at Chapel Hill Nutrition Research Institute
Kannapolis, North Carolina, 28081, United States
NCT Number: NCT01823419
The purpose of this study is to investigate the role of the ratio of omega-6 to omega-3 fatty acids on executive functions. The investigators hypothesize that participants ages 7-9 years with a ratio closer to 4:1 will do better on tests of executive function than participants with a ratio closer to the purported Western diet norm of 15:1.
Looking for future studies?
Notify Me7 year–9 year
All sexes
Observational
Kannapolis, North Carolina, 28081, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 10 days
Executive function will be measured using a validated and standardized system known as CANTAB (Cambridge Neuropsychological Test Automated Battery) and correlated with the ratio of fatty acid intake. 24-hour diet recalls will be completed using the NDSR (Nutrient Data System for Research) software. Across one week, the children will be interviewed 3 times (two weekdays, one weekend day) about what they ate in the previous 24 hours. The dietary data will be averaged to arrive at the n-6/n-3 intake. The children will then come to lab for one visit where they will be assessed using the CANTAB.
Time frame: Baseline
Temperament will be measured using a Rothbart written assessment completed by the caregiver.
Time frame: Baseline
Demographic information will be collected from caregiver using a lab-typical questionnaire.
University of North Carolina, Chapel Hill
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03699800
Agraphia, Communication Disorders
Evora, Portugal
View Trial DetailsNCT03699787
Agraphia, Communication Disorders
Evora, Portugal
View Trial DetailsNCT03518346
Autism, Autism Spectrum Disorder
Sacramento, California, United States
View Trial DetailsNCT04631042
Anxiety Disorders, Attention Deficit Disorder with Hyperactivity
Bethesda, Maryland, United States
View Trial Details